1. Combined Inhibition of TGF-β Signaling and the PD-L1 Immune Checkpoint Is Differentially Effective in Tumor Models
   Heng Sow et al, 2019, Cells CrossRef
2. Papillary thyroid carcinoma with a high tumor mutation burden has a poor prognosis
   Zhenyu Xie et al, 2020, International Immunopharmacology CrossRef
3. The Clinical Implications of Tumor Mutational Burden in Osteosarcoma
   Lu Xie et al, 2021, Frontiers in Oncology CrossRef